Tipifarnib is a nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction. By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Zarnestra and tipifarnibum. Its PubChem CID is 159324.
Tipifarnib
| CAS No | 192185-72-1 |
|---|---|
| Molecular Formula | C27H22Cl2N4O |
| Molecular Weight | 489.4 g/mol |
| Synonyms | 6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tipifarnib is a nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction.
The listed CAS number is 192185-72-1.
The listed molecular formula is C27H22Cl2N4O.
The listed molecular weight is 489.4 g/mol.
6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one.
The source lists Zarnestra and tipifarnibum.